Cardiac MR software developer Myocardial Solutions has received clearance from the U.S. Food and Drug Administration (FDA) for the latest version of its MyoStrain software.
MyoStrain is a 10-minute, MRI-based heart function test that provides physicians with diagnostic markers to support the early assessment of heart dysfunction. MyoStrain 6.0 introduces a suite of new features, with initial feedback from technicians and physicians pointing to improved user experience, ease of access to centralized information, and the benefits of having organized data, the company said.
